Covid-19 roundup: Despite treatment shortages, some US pharmacies report pile-ups of Merck's antiviral
The federal government has only sent four shipments of Merck’s Covid-19 antiviral molnupiravir (about 400,000 courses in each shipment) nationwide, and already HHS is reporting …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.